How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?
Topic:
Atrial Fibrillation (AF)
Sponsored by Roche
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Pieter Kamphuisen
Tergooi MC, Hilversum (Netherlands (The))
1
presentation
0
follower
2 more presentations in this session
Bleeding risk as one of major hurdles in stroke prevention therapy prescription.
Speaker: Professor C. Granger (Durham, US)
Novel biomarker-based risk scores for better stratification of stroke and major bleeding risk in AF patients and OAC therapy optimization.
Speaker: Associate Professor Z. Hijazi (Uppsala, SE)
Access the full session
Biomarker-based approaches for improved atrial fibrillation management
Speakers:
Professor P. Kamphuisen, Professor C. Granger, Associate Professor Z. Hijazi
About the event
ESC 365 is supported by
